skip to Main Content

블록 체인을 이용한 조기 유방암 검사

1 token = 0,00026 ETH

10 tokens = 1 Breast Cancer Test

1 BC test = 100 – 500$ (국가에 달려있다.)

사전 판매 완료!
토큰 합계 발행 : $883.323


ARNA 토큰 세일이 시작되었습니다.
지금 가입하세요!

1 (1)
ARNA Panacea ICO rating
награда

ARNA 토큰의 유틸리티 기능을 지금 사용할 수 있습니다.

ARNA 토큰 10 개를 1 개로 변경할 수 있습니다.ARNA BC test.
ARNA BC 대기자 명단은 2017 년 12 월 21 일에 열립니다.
지금 대기자 명단에 올라서 수백만 명이 앞설 수 있도록.

연구개발에 관여하는 혁신적인 바이오텍 회사와 블록체인

생태계 ANRA Panacea를 사용해서 암 질병 초기 진단 방법을 론칭하는 바이오텍 시장 ARNA Genomics에 들어올 기회입니다.

overview

ARNA BC 는 고 정확성을 갖은 초기 유방암 진단의 최초 개발된 제품입니다.

ARNA는 무엇인가

ARNA 자문위원 Dmitry Kulish는 ARNA 프로젝트와 블록체인에 대해서 얘기합니다. 풀 인터뷰

ARNA Genomics Intro

ARNA Panacea 소개

ARNA Panacea 는 바이오텍 분산형 솔루션입니다. 블록체인과 ARNA 토큰의 힘으로,

ARNA Panacea 는 임상 실험 절차를 할 수 있는 플랫폼일 뿐만 아니라, 연구원들이 연구 개발 단계 기간 동안 임상 실험에 관여하는 모든 종류의 시장 참여자에게 마켓플레이스를 제공하고 최종 바이오텍 제품을 소비자들(환자들)에게 직접 판매를 할 수 있게 지원도록 디자인되었습니다.

정확성
할 수있다 2018
96.04%
True: 97 False: 4
laptop

ARNA Panacea 사용 케이스들

연구의 증명

연구의 증명

공개 블록체인 ARNA Panacea에 저장된 데이터는 증거 기반에 근거를 둡니다.

보호된 연구

보호된 연구

블록체인 생태계내에서 암호화된 키를 사용해서 안전하 포맷으로 “과학적 연구”를 할 수 있는 능력

빅 데이터

빅 데이터

가용한 데이터를 분석하는데 필요한 기능성의 open API를 통해서, 축적된 배열의 정보에 글로벌 엑세스

생태계

생태계

진단과 암 치료 방법의 정보를 수집, 저장, 분석을 위한 단독 블록체인 플랫폼

스마트 블록체인

스마트 블록체인

암 치료의 새로운 방법들을 개발하기 위한 “패턴”을 찾기 위한 인공지능에 연결하는 가능성

ARNA 토큰

ARNA 토큰

환자, 연구원, 규제기관, CRO, 제약회사, 병원의 생태계 내에서의 상호 작용을 통한 사용법

우리의 시장은 거대합니다

0
전세계 여성들이 매년
0
수 천의 바이오텍 연구자들
0천만
ARNA BC 테스트가 미국과 러시아에서
$0B+
지난 3년 동안 매 해 동안 의료 산업에서 인수 합병 거래

ARNA Panacea 블록 체인 생태계

공동체 역할

  • 01 등록자
  • 02 연구원
  • 03 보험 회사
  • 04 제약 회사
  • 05 계약 연구 기관 (CRO)
  • 06 스폰서 / 투자자
  • 07 국가 윤리위원회
  • 08 MDs
  • 09 클리닉
  • 10 전문가
  • 11 조정기
  • 12 빅 데이터
  • 13 환자
  • 14 통계

우리의 비전

블록체인 기술을 사용해서 대중에게 론칭함으로써, 암과 싸우는 목표를 하는 바이오텍 기술의 도전적인 방법으로 혁신합니다.

Egor Melnikov

Egor Melnikov

Founder, CEO

More than 10 years ago started the project with mission to save lives from cancer. Economist and manager by education, entrepreneur by experience and spirit. Made several successful startups as founder and co-founder in advertising and production business, international logistics, IT solutions for large-scale projects, was CEO of international telecom operator. ARNA – is the meaning of Egor’s life.

George Nikitin

George Nikitin

Co-founder and COO, blockchain platform ideologist

Master of physics (diploma with honors), have 14 articles and inventions. Successfully worked in large international companies (Delloite, etc.), as well as in private equity companies. He has extensive experience as executive manager in various major private and public companies in IT, telecom, oil&gas.

Anatoliy Melnikov

Anatoliy Melnikov

Co-founder and HEAD of R&D, creator of ARNA tests

Having more than 40 years of experience in molecular biology and genetics, he is the author and co-author of more than 50 scientific articles and number of patents. For 15 years he worked in the USA in oncological centers, before that – in Canada, Hungary in various scientific companies, and Russia – a branch of the Institute of Bioorganic Chemistry of the Russian Academy of Sciences and the Institute of Biochemistry and Physiology of Microorganisms of the Russian Academy of Sciences. He graduated from the biological faculty of the Lomonosov Moscow State University.

Ilya Senechkin

Ilya Senechkin

PhD in Life Sciences, Embryology Director ("Center IVF" network of clinics, Russia)

Development Manager for Scientific and Educational Programs (F. Paulsen Assisted Reproductive Technologies Center, Russian Ministry of Health). Former: medical advisor (MC Femina, Vitrolife), clinical embryologist (MD Medical Group), Jr. scientist (Wageningen University, The Netherlands)

Magomed Chatuev

Magomed Chatuev

Software architect and developer

CTO. Has a big experience working with start-ups in the areas of e-commerce, PR & Marketing, finance, transportation, ERP development. Mainly focused on building SaaS, APIs & complex business processes automation. Had been working in international companies in Russia, Ireland, and Germany.

Alexander Mazaletskiy

Alexander Mazaletskiy

Software Architect

Founder, CEO and Principal engineer in blockchain integrator Dicoiner (www.dicoiner.com) Founder and CEO in mobile development studio Zero Cool Team. 10 years experience in enterprise fintech software design and development. Last two yeast making research and implementation of blockchain systems. Graduate of IIDF-2015(Internet Initiatives Development Fund) in the team of Teslawatch startup.
15 scientific publications in the field of natural language processing

Sergey Dolgachev

Sergey Dolgachev

Co-founder, head of finance and risks management

Entrepreneur and co-owner of several companies in the oilfield service, medicine and biotech. He graduated from the Faculty of Computational Mathematics and Cybernetics of the Moscow State University Lomonosov, EMBA Higher School of Economics, studied at the Skolkovo Management School, INSEAD and graduate school of MGIMO. He has extensive executive experience in oil&gas public and private companies.

Vladimir Savanovich

Vladimir Savanovich

Co-founder, Head of Investor Relations

has a master’s degree in physics. During his professional experience, he worked in various business areas, mainly focusing on the active development of the contractual base of enterprises. He has experience in working in a Western consulting company, a resort development company, a Swiss investment fund and a Russian exploration company.

자문 위원

Linda S. Pellicore

Linda S. Pellicore

Linda S. Pellicore graduated from Thomas Jefferson Medical College of Graduate Studies, Philadelphia, PA, with Ph.D.s in both Pharmacology and Toxicology, in 1987. She has 28 years expertise in New Drug Applications, Biologics, 510Ks, Food Additives and Dietary Supplements with the U.S. Food and Drug Administration, serving as the agency’s Senior Pharmacologist. She is a National Research Council Fellow, and is a member of numerous professional scientific societies.

Wesley Hymer, Ph.D

Wesley Hymer, Ph.D

Dr. Hymer is an Emeritus Professor of Biochemistry at Penn State and winner of Penn State’s Faculty Scholar Medal for Life and Medical Sciences. He has countless academic papers, grants and including several patents that were developed when he was Director of Penn State’s Center for Cell Research, and one patent related to medical devices enabling targeted chemotherapy for cancers treatments. He collaborated with NASA on biotechnology and biomedical experiments in microgravity and developed unique electrophoresis experiments executed on board the U.S. Space Shuttle and microsatellites.

Dmitry Kulish

Dmitry Kulish

Dmitry Kulish is an independent expert in the fields of strategic, organizational and technological development of pharmaceutical products. Dmitry holds a PhD in Biology, has been a postdoc at Harvard Medical School, earned MBA from the Wharton Business School, the Institute of Molecular Genetics of the Russian Academy of Sciences, and the Moscow State Institute of Molecular Biology Lomonosov Moscow State University.

Dmitry Grigoriev

Dmitry Grigoriev

Over 20 years of successful general management experience with a particular focus on business development and operational excellence. Сonstant over 5 years trend in business development and financial results improvement for large European integrated company with over 8 bln. USD in turnover and presence in over 15 countries. Has implemented several very successful business alliances strategies where the managed companies/clients have benefited from new distribution channels/partners reach.

Ph.D DR. Soenke Bartling

Ph.D DR. Soenke Bartling

Ph.D DR. MED, Board certified Radiologist, blockchain for research & healthcare / Open Science. Sönke has a tremendous background in neuroradiology at Hannover Medical School, Institute for Radiology and Interventional Therapy and other sound scientific organizations. Apart from that Sönke is well-known due to his activity in Web 2.0 for science in 00x, following by working on Blockchain for Science and Open Science (awarded in 2015, Germany land of ideas) concepts. He is author of more than 20 scientific publications, number of reviews, books and 6 patents. Holds various awards and is a member of governmental groups on radiology and tomography.
Mikhail Groubman

Mikhail Groubman

Mikhail joined Atlant Clinical in 2012 as Chief Executive Officer and as a member of the Board of Directors. Prior to Atlant Clinical he worked at GlaxoSmithKline where he started as a clinical research assistant, later becoming a local study manager in the oncology group. He subsequently joined the Moscow Sales Department, where he rose to become Regional Market Access Director. Mikhail graduated from Lomonosov Moscow State University with Master degrees in biochemistry and management.

Marina Sekacheva

Marina Sekacheva

is a Doctor of Medical Sciences, a laureate of the Russian Government Prize in Science, a holder of post-doctoral degree in medicine of the Technical University of Munich, the Director of the Center for Personalized Oncology Sechenov OncoTarget, established as part of the Institute of Personalized Medicine in 2017

Ilya N. Chistyakov

Ilya N. Chistyakov

MD., PhD, founder and CEO of the Preclinical Study Centre LLC, managing company of “Pharma Valley” biotechnological cluster – the only GLP OECD in Russia, an independent hybrid CRO specialized on conducting a full cycle of pharmacological development, manufacturing, preclinical and clinical studies of biotechnological, biosimilar and generic medicines.

Ed Kanalosh

Ed Kanalosh

has more than 20 years of experience in biotech investments and strategic consulting. Partner of venture fund “Maxwell Biotech” (Moscow), director of consulting company Candesic (London). Edward is an acting head of Investment Service of Skolkovo fund, vice-president of Investment Bank “Trust” and consultant of New Jersey office of McKinsey company. His career has started in Bill and Melinda Gates Foundation Fund. MBA from Harvard Business School, MD with PhD.

Alex Kosik

Alex Kosik

Dr. Alex Kоsik is a successful serial technology entrepreneur. His focus is in Life Sciences, Medical Devices, FDA Compliance, Evidence-Based Medicine, Venture Capital and M&A. Alex is a recognized technology due diligence expert and senior analyst to several VC’s, angels, Gerson Lehrman Group and institutional investors. He co-founded multiple businesses himself, met Bill Gates, sold his “G1 Gravitonus workstations” to Forbes-100, and ranked 3rd by Becker’s Spine Review of “10 spine orthopedic surgeon tech entrepreneurs to know”

Sergey Borovskiy

Sergey Borovskiy

worked and lived in China since 1991. He has more than 20 years of experience in international management in China and Hong Kong. He held the positions of Chairman of the Board of Directors in various companies in China involved in international trade, investment and production. Since 2017, he was the General Manager of Sanju Environmental Protection (Hong Kong) Limited, coordinating the international projects of the controlling shareholder.

토큰의 기능성은 무엇입니까

B2 Dir

JANET WOODCOCK – (식품 의약품 안전청의 의약품 평가 연구 센터 책임자)

“나는 많은 다른 사람들처럼 우리가 지금 가지고있는 임상 시험 시스템이 고장 났다고 개인적으로 믿습니다. 우리가 필요로하는 목표를 달성하기 위해 노력하고 있지 않습니다.”

  • 주요 판매 이벤트(0.80불)에서 10개의 토큰은 1 ARNA BC 테스트를 구매하는데 사용됩니다. 하나의 ARNA BC 테스트의 예상되는 평균 시장 가격은 100불입니다.
  • 토큰 대량 보유자는 ARNA VIP 보상 프로그램에, 자격이 있고, 이례적인 기회를 받습니다.
  • ARNA 토큰은 플랫폼 참여자들에게 지급 수단의 암호 화폐로 ARNA Panacea 플랫폼에서 사용됩니다.
  • 연구원들은 바이오텍의 돌파구 발명을 위한 “크라우드펀딩”을 수행 할 수 있습니다.
  • …다른 사용법은 백서를 읽어 주십시오.

토큰과 자금

ARNA at conferences

[big-v2]conference2

Moscow

International blockchain forum

[big-v2]conference3

Monaco 

MGF Holiday Blockchain Edition CryptoBazar Exclusive

[big-v2]conference1

New York

Blockchain economic forum 2017

[big-v2]conference5

Hong Kong

The 30th Annual AVCJ Private Equity & Venture Forum

[big-v2]conference6

Los Angeles

World funding summit & capital expo

[big-v2]conference4

Santa Clara

Blockchain in the healthcare system

문서

One Pager

ARNA market overview

Whitepaper

whitepaper

Market Overview

Market Overview

로드맵

2013 2019
[carousel_anything]

2013

ARNA Genomics 설립
Skolkovo 생의학 클러스터 회원 지위 획득

2014

시드 라운드; 암의학 질병의 존재 여부 테스트인,
ARNA-Thermometr 개발; “노우 하우” 목표 형식화

2015

ARNA 유방암 개발 – 유방암 초기 진단을 위한 고 정밀도 테스트

2016

ARNA 대장암 개발; ARNA BC 개발 종료; ARNA BC의 실험실 테스트 시작; 특허 신청서 1호 제출

2017

ARNA BC; 실험실 테스트 종료; Sechenov 대학과 ARNA BC 임상 공동 연구 시작; 특허 회사 조약 1호 신청서 제출; 토큰 배포 이벤트

2018

미국내에서 오피스와 첫 실험실 오픈. 특허 회사 조약 2호, 3호 신청서 제출. ARNA BC를 위한 규제 정책에 관한 동의 미국 FDA와 함께 임상 연구소 1호 론칭 ARNA CC 개발 완료, 실험실 연구 시작. ARNA Panacea-베타 버전의 블록체인 생태계 론칭, 개발자를 위한 기초 문서화

2019

관심있는 시장 플레이어(규제 기관, 투자자, 사용자, 등.)에 의한 ARNA Panacea의 블록체인 생태계의 사용 개발 시작: ARNA Lung, ARNA Liver, ARNA Pancreas; ARNA BC의 미국 시장 진입; 중국에서 임상 실험; 국가적 단계: 미국, 중국, 인도, 유럽, 영국, 이스라엘, 브라질; Seed round B; 첫 소득을 받음

[/carousel_anything]

파트너

미디어

logo-300×77
steemit
NewsBTC-Logo
logo-home-new
forclog
coin-min
logo
Безымянный
tokenmarket
coingecko-logo
cryptocoinsnews-vector-kopi-1-1
smith+crown
3423420
1.Bitcoininsider
2.Themerkle
3. THE COINTELEGRAPH 11
4.Huffpost
5.NEWS